PIER MARIA FORNASARI

PIER MARIA FORNASARI
2019-11-28

BIOLOGICS ALLIANCE™ INITIATES COLLABORATION WITHIN ORTHOPAEDICS COMMUNITY

For the first time, The Arthroscopy Association of North America (AANA), the American Orthopaedic Society for Sports Medicine (AOSSM), the International Cartilage Repair Society (ICRS) and the ON Foundation have collaborated to form The Biologics Alliance (BA)™, an orthopaedic organization dedicated to providing one voice for all matters on musculoskeletal biologics and regenerative medicine. Recently, randomized clinical trials and clinical practice guidelines

No Comments InREGENERATIVE MEDICINE

PIER MARIA FORNASARI
2019-11-28

Wind-down of stem-cell institute leaves a void

Funds paved the way for rigorous tests of therapies, but unintentionally boosted a market for potentially dangerous fakes, says Jeanne F. Loring. Source Nature For the past dozen or so years, stem-cell researchers in California have been the envy of the world. In 2004, as a rebuke to the restrictions put in place in the

No Comments InREGENERATIVE MEDICINE

PIER MARIA FORNASARI
2019-11-28

Investment in UK cell and gene therapy manufacturing set to continue

New data released shows cell and gene therapy manufacturing facilities are rapidly becoming operational reflecting job expansion in the sector. Additional 6,000m2 of cell and gene therapy manufacturing space expected to become available within the next 12 months. The Cell and Gene Therapy Catapult (CGT Catapult) published the sixth annual UK cell and gene therapy

No Comments InCELL THERAPY GENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2019-11-21

Researchers Organize Stem Cells Based on a Computational Model

Researchers were able to apply a machine-learning computational model to arrange stem cells into different shapes. The holy grail of medical advancements is being able to create organs out of one’s own cells. But to do that researchers have to organize stem cells into predictable patterns, which has been quite a struggle. 3-D printing is one approach

No Comments InMACHINE LEARNING

PIER MARIA FORNASARI
2019-11-20

New Process can 3D Print Living Cells with Precision and Speed

A novel bioink can integrate living cells into 3D scaffolds at a speed of one meter per second, making it possible to study the spread of diseases and produce tailor-made tissue. 3D bioprinting has come a long way in recent years, with scientists using living tissue to print organs as complex as human skin. Researchers in

No Comments InBIOPRINTING

PIER MARIA FORNASARI
2019-11-13

Project Nightingale: Google accesses trove of US patient data

Google has gained access to a huge trove of US patient data – without the need to notify those patients – thanks to a deal with a major health firm. The scheme, dubbed Project Nightingale, was agreed with Ascension, which hopes to develop artificial intelligence tools for doctors. Google can access health records, names and

No Comments InDIGITAL HEALTH

PIER MARIA FORNASARI
2019-11-11

Liquid-in-liquid printing method could be used for bioprinting organs

Liquid-in-liquid 3D printing was first presented in a BMW funded MIT project. Although the project initially seemed limited in scope the possibilities of 3D printing within a liquid medium opens new opportunities in terms of escaping gravitational pull and thus producing parts that require a more volumetric approach, such as biological structures and organs. As reported

No Comments InBIOPRINTING

PIER MARIA FORNASARI
2019-11-10

Wnt Signaling in 3D: Recent Advances in the Applications of Intestinal Organoids

Using organoid technology, adult epithelial stem cells can be expanded in vitro to generate self organizing 3D epithelial structures that closely recapitulate the architecture and cellular composition of the tissue of origin. Because of their strict dependence on Wnt ligands for survival and growth, intestinal organoids have become the tool of choice for in vitro

No Comments InORGAN ON CHIP

PIER MARIA FORNASARI
2019-11-09

EU Regulations Are Holding Back Gene and Cell Therapy Clinical Trials

European regulations might be responsible for lower numbers of advanced therapy clinical trials running in the region when compared to the US and Asia. Europe has historically been a pioneer in advanced therapies, such as cell and gene therapy. Europe was the first region to approve a gene therapy, and it boasts the highest number

No Comments InGENE THERAPY RARE DISEASES

PIER MARIA FORNASARI
2019-11-08

Athenex Announces European Commission Grants Orphan Designations for Paclitaxel and Encequidar for the Treatment of Soft Tissue Sarcoma

Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it has received Orphan Designations from the European Commission (EC) for paclitaxel and encequidar (“Oral Paclitaxel”) for the treatment of soft tissue sarcoma, following a positive opinion from the

No Comments InCANCER

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

All posts by PIER MARIA FORNASARI

BIOLOGICS ALLIANCE™ INITIATES COLLABORATION WITHIN ORTHOPAEDICS COMMUNITY

Wind-down of stem-cell institute leaves a void

Investment in UK cell and gene therapy manufacturing set to continue

Researchers Organize Stem Cells Based on a Computational Model

New Process can 3D Print Living Cells with Precision and Speed

Project Nightingale: Google accesses trove of US patient data

Liquid-in-liquid printing method could be used for bioprinting organs

Wnt Signaling in 3D: Recent Advances in the Applications of Intestinal Organoids

EU Regulations Are Holding Back Gene and Cell Therapy Clinical Trials

Athenex Announces European Commission Grants Orphan Designations for Paclitaxel and Encequidar for the Treatment of Soft Tissue Sarcoma